Is It Time To Reconsider Agilent Technologies (A) After Recent Share Price Weakness

ScienceWolves are reconquering Europe. Can people learn to live with them?

Clinical OMICsFirst Novel Antifungal for Aspergillus in 20 Years Succeeds in Phase III

BioWorldMoney raised by biopharma

BioWorldBiopharma money raised: Jan. 1-June 18, 2026

Endpoints NewsTreasury weighs screening investments in China biotech

BioPharma DivecAMPfield lands $180M to build gut disease drug

Endpoints NewsNovo Nordisk expands in China and Czech; Cellares boosts Series D by $50M

BioPharma DiveBiogen adds more immune drugs in $1B buyout of secretive startup Raythera

Promega BlogWhat Happens When You Delay an Ebola Vaccine Booster by 18 Months?

FierceBiotechcAMPfield harvests $180M series A to advance oral IBD drug licensed from Newsoara

Endpoints NewsIRA's Medicare out-of-pocket cap increased access to drugs, study finds

BioWorldVRBPAC adcom to vote on Moderna flu vaccine